Consequently, researchers can review available documentation and product specifications before incorporating materials into their research programs
321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or function of the body." FDA's letters to the other manufacturers are similar in their complaints about why their products fall under the agency's regulatory oversight and why the companies are not allowed to market them, despite their oft-cited claims that the products, especially the triple agonists, are for research only
Potential role of microbiome in chronic fatigue syndrome/myalgic encephalomyelits (CFS/ME)
The outcomes for those compounds are still uncertain
These limits slow cellular response and structural change, which extends study timelines compared to soft tissue, where blood flow supports faster inflammatory and structural responses
This is the most-asked question about this stack